Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol. 2001;1(2):108–16. https://doi.org/10.1038/35100503.

Article  CAS  PubMed  Google Scholar 

Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313–26. https://doi.org/10.1089/jir.2008.0027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Panee J. Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine. 2012;60(1):1–12. https://doi.org/10.1016/j.cyto.2012.06.018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahad DJ, Ransohoff RM. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol. 2003;15(1):23–32. https://doi.org/10.1016/s1044-5323(02)00125-2.

Article  CAS  PubMed  Google Scholar 

Tong X, Zeng H, Gu P, Wang K, Zhang H, Lin X. Monocyte chemoattractant protein–1 promotes the proliferation, migration and differentiation potential of fibroblast–like synoviocytes via the PI3K/P38 cellular signaling pathway. Mol Med Rep. 2020;21(3):1623–32. https://doi.org/10.3892/mmr.2020.10969.

Article  CAS  PubMed  Google Scholar 

Conti I, Rollins BJ. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol. 2004;14(3):149–54. https://doi.org/10.1016/j.semcancer.2003.10.009.

Article  CAS  PubMed  Google Scholar 

Georgakis MK, Gill D, Rannikmäe K, Traylor M, Anderson CD, Lee JM, et al. Genetically determined levels of circulating cytokines and risk of stroke. Circulation. 2019;139(2):256–68. https://doi.org/10.1161/circulationaha.118.035905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gholamalizadeh H, Ensan B, Sukhorukov VN, Sahebkar A. Targeting the CCL2-CCR2 signaling pathway: potential implications of statins beyond cardiovascular diseases. J Pharm Pharmacol. 2024;76(2):138–53. https://doi.org/10.1093/jpp/rgad112.

Article  PubMed  Google Scholar 

Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the Cardiovascular System. Circ Res. 2017;120(1):229–43. https://doi.org/10.1161/circresaha.116.308537.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sirtori CR. The pharmacology of statins. Pharmacol Res. 2014;88:3–11.

Article  CAS  PubMed  Google Scholar 

Amin F, Fathi F, Reiner Ž, Banach M, Sahebkar A. The role of statins in lung cancer. Archives Med Sci. 2022;18(1):141–52. https://doi.org/10.5114/aoms/123225.

Article  CAS  Google Scholar 

Chamani S, Liberale L, Mobasheri L, Montecucco F, Al-Rasadi K, Jamialahmadi T, et al. The role of statins in the differentiation and function of bone cells. Eur J Clin Invest. 2021;51(7). https://doi.org/10.1111/eci.13534.

Chruściel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194–208. https://doi.org/10.1016/j.atherosclerosis.2016.07.897.

Article  CAS  PubMed  Google Scholar 

Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021;12(2):237–51. https://doi.org/10.1002/jcsm.12654.

Article  PubMed  PubMed Central  Google Scholar 

Sahebkar A, Kiaie N, Gorabi AM, Mannarino MR, Bainaconi V, Jamialahmadi T, et al. A comprehensive review on the lipid and pleiotropic effects of pitavastatin. Prog Lipid Res. 2021;84. https://doi.org/10.1016/j.plipres.2021.101127.

Vahedian-Azimi A, Beni FH, Fras Z, Banach M, Mohammadi SM, Jamialahmadi T, et al. Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis. Archives Med Sci. 2023;19(4):952–64. https://doi.org/10.5114/aoms/159992.

Article  CAS  Google Scholar 

Vahedian-Azimi A, Mannarino MR, Shojaie S, Rahimibashar F, Galeh HEG, Banach M, et al. Effect of statins on prevalence and mortality of Influenza Virus infection: a systematic review and Meta-analysis. Archives Med Sci. 2022;18(6). https://doi.org/10.5114/AOMS/149633.

Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S, et al. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the akt pathway. Arterioscler Thromb Vasc Biol. 2010;30(11):2205–11. https://doi.org/10.1161/atvbaha.110.210500.

Article  CAS  PubMed  Google Scholar 

Serban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GYH, et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep. 2015;5. https://doi.org/10.1038/srep09902.

Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103(24):2885–90. https://doi.org/10.1161/hc2401.092816.

Article  CAS  PubMed  Google Scholar 

Khattri S, Zandman-Goddard G. Statins and autoimmunity. Immunol Res. 2013;56(2–3):348–57. https://doi.org/10.1007/s12026-013-8409-8.

Article  CAS  PubMed  Google Scholar 

Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A. Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res. 2018;135:230–8. https://doi.org/10.1016/j.phrs.2018.08.014.

Article  CAS  PubMed  Google Scholar 

Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46(4):333–40. https://doi.org/10.1007/s11745-010-3517-x.

Article  CAS  PubMed  Google Scholar 

Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GYH, Muntner P, et al. Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2015;114(3):546–57. https://doi.org/10.1160/TH14-11-0937.

Article  PubMed  Google Scholar 

Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of statin therapy on plasma levels of Von Willebrand factor antigen: systematic review and meta-analysis of Randomised placebo-controlled trials. Thromb Haemost. 2016;115(3):520–32. https://doi.org/10.1160/TH15-08-0620.

Article  PubMed  Google Scholar 

Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Med Clin (Barc). 2018;150(10):398–402. https://doi.org/10.1016/j.medcli.2017.11.030.

Article  PubMed  Google Scholar 

Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–74. https://doi.org/10.1038/nature01323.

Article  CAS  PubMed  Google Scholar 

Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5(8):927–46.

PubMed  PubMed Central  Google Scholar 

Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 1999;19(6):1518–25. https://doi.org/10.1161/01.atv.19.6.1518.

Article  CAS  PubMed  Google Scholar 

Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991;88(12):5252–6. https://doi.org/10.1073/pnas.88.12.5252.

Article  PubMed  PubMed Central  Google Scholar 

Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1999;103(6):773–8. https://doi.org/10.1172/jci5624.

Article  CAS  PubMed  PubMed Central